Hepatitis B vaccination: Half dose recombinant DNA hepatitis B vaccine (B-Hepavac II) is as immunogenic as the full recommended dose in healthy adults
- 1 August 1991
- journal article
- clinical trial
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 6 (4) , 374-376
- https://doi.org/10.1111/j.1440-1746.1991.tb00874.x
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Overview of clinical studies with hepatitis B vaccine made by recombinant DNAJournal of Infection, 1986
- Recombinant yeast hepatitis B vaccine compared with plasma-derived vaccine: Immunogenicity and effect of a booster doseJournal of Infection, 1986
- Safety and immunogenicity of a recombinant hepatitis B vaccineJournal of Medical Virology, 1985
- Viral Hepatitis VaccinesAnnual Review of Medicine, 1985
- HEPATITIS B VACCINATION: HOW LONG DOES PROTECTION LAST?The Lancet, 1984